Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kwong Ng
Observed name:
Ng, Kwong
Institution:
Ministry of Health
Observed institutions:
Ministry of Health,
National Taiwan University,
National Taiwan University Hospital,
Calvary Mater Newcastle Hospital,
National Cheng Kung University
ORCID:
0000-0002-6511-1639
Observed ORCID:
0000-0002-6511-1639
OpenAlex ID:
A5004172745
Comorbidity profiles of chronic migraine sufferers in a national database in Taiwan
2012
·
Yong-Chen Chen
, Chao-Hsiun Tang
, et al.
·
The Journal of Headache and Pain
·
99
PDF
Comparisons of disability, quality of life, and resource use between chronic and episodic migraineurs: A clinic-based study in Taiwan
2012
·
Shuu-Jiun Wang
, Po-Jen Wang
, et al.
·
Cephalalgia
·
96
Comparative efficacy of inhaled medications (ICS/LABA, LAMA, LAMA/LABA and SAMA) for COPD: a systematic review and network meta-analysis
2018
·
Mohamed Ismail Abdul Aziz
, Ling Eng Tan
, et al.
·
International Journal of COPD
·
60
PDF
Impact of overactive bladder on quality of life and resource use: results from Korean Burden of Incontinence Study (KOBIS)
2015
·
Kyu Sung Lee
, Myung Soo Choo
, et al.
·
Health and Quality of Life Outcomes
·
45
PDF
Cost-effectiveness analysis of bilateral cochlear implants for children with severe-to-profound sensorineural hearing loss in both ears in Singapore
2019
·
Li-Jen Cheng
, Swee Sung Soon
, et al.
·
PLoS ONE
·
42
PDF
Cost-effectiveness of sacubitril/valsartan versus enalapril in patients with heart failure and reduced ejection fraction
2017
·
Lin Liang
, David Bin-Chia Wu
, et al.
·
Journal of Medical Economics
·
38
PDF
Cost-effectiveness analysis of atezolizumab in advanced triple-negative breast cancer
2020
·
Lee Cheng Phua
, Soo Chin Lee
, et al.
·
BMC Health Services Research
·
36
PDF
Health Technology Assessment and Its Use in Drug Policies: Singapore
2018
·
Fiona Pearce
, Liang Lin
, et al.
·
Value in Health Regional Issues
·
35
Cost utility analysis of tisagenlecleucel vs salvage chemotherapy in the treatment of relapsed/refractory diffuse large B-cell lymphoma from Singapore’s healthcare system perspective
2020
·
Boon Piang Cher
, Kar Yee Gan
, et al.
·
Journal of Medical Economics
·
33
PDF
Cost effectiveness analysis of afatinib versus pemetrexed-cisplatin for first-line treatment of locally advanced or metastatic EGFR mutation positive non-small-cell lung cancer from the Singapore healthcare payer’s perspective
2018
·
Ping-Tee Tan
, Mohamed Ismail Abdul Aziz
, et al.
·
BMC Cancer
·
29
PDF
Cost-effectiveness analysis of pembrolizumab monotherapy versus chemotherapy for previously untreated advanced non-small cell lung cancer
2020
·
Mohamed Ismail Abdul Aziz
, Ling Eng Tan
, et al.
·
Journal of Medical Economics
·
28
PDF
Cost-effectiveness analysis of osimertinib for first-line treatment of locally advanced or metastatic EGFR mutation positive non-small cell lung cancer in Singapore
2020
·
Mohamed Ismail Abdul Aziz
, Wayne Yong Xiang Foo
, et al.
·
Journal of Medical Economics
·
26
PDF
Assessing the cost-effectiveness of mepolizumab as add-on therapy to standard of care for severe eosinophilic asthma in Singapore
2020
·
Ling Eng Tan
, Wan Hui Gloria Tan
, et al.
·
Journal of Asthma
·
22
PDF
Mapping of Incontinence Quality of Life (I-QOL) scores to Assessment of Quality of Life 8D (AQoL-8D) utilities in patients with idiopathic overactive bladder
2014
·
Gang Chen
, Jonathan T Tan
, et al.
·
Health and Quality of Life Outcomes
·
20
PDF
Cost-Effectiveness Analysis of Sunitinib versus Interferon-Alfa for First-Line Treatment of Advanced and/or Metastatic Renal Cell Carcinoma in Singapore
2019
·
Sil-ling Pruis
, Mohamed Ismail Abdul Aziz
, et al.
·
International Journal of Technology Assessment in Health Care
·
18
PDF
Cost-effectiveness analysis of the nonavalent human papillomavirus vaccine for the prevention of cervical cancer in Singapore
2021
·
Lee Cheng Phua
, Horace C.W. Choi
, et al.
·
Vaccine
·
17
Cost-effectiveness of olaparib maintenance therapy when used with and without restriction by BRCA1/2 mutation status for platinum-sensitive relapsed ovarian cancer
2021
·
Li-Jen Cheng
, Grace Wong
, et al.
·
Expert Review of Pharmacoeconomics & Outcomes Research
·
15
Cost-effectiveness of pertuzumab and trastuzumab biosimilar combination therapy as initial treatment for HER2-positive metastatic breast cancer in Singapore
2021
·
Li-Jen Cheng
, Lydia Loke
, et al.
·
Expert Review of Pharmacoeconomics & Outcomes Research
·
15
Real-world evaluation of sodium-glucose co-transporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors for managing type 2 diabetes mellitus: a retrospective multi-ethnic cohort study
2022
·
Louise Gek Huang Goh
, Jiandong Sun
, et al.
·
Journal of Diabetes & Metabolic Disorders
·
14
PDF
Impact of Value-Driven Healthcare Strategies for Biosimilar Adoption: The Singapore Story
2024
·
She Hui Tan
, Louise Gek Huang Goh
, et al.
·
PharmacoEconomics - Open
·
13
Concordance Between Patient and Clinician Assessment of Dry Eye Severity and Treatment Response in Taiwan
2015
·
Po-Ting Yeh
, Hsu-Chih Chien
, et al.
·
Cornea
·
12
Cost‐effectiveness of ribociclib as initial treatment for premenopausal women with advanced breast cancer in Singapore
2020
·
Lydia Loke
, Soo‐Chin Lee
, et al.
·
Cancer Reports
·
11
PDF
Developing a New Region-Specific Preference-Based Measure in East and Southeast Asia
2022
·
Takeru Shiroiwa
, Tatsunori Murata
, et al.
·
Value in Health Regional Issues
·
10
Cost-effectiveness of daratumumab in combination with lenalidomide and dexamethasone for relapsed and/or refractory multiple myeloma
2021
·
Xin Yi Wong
, Wee Joo Chng
, et al.
·
Expert Review of Pharmacoeconomics & Outcomes Research
·
10
A Retrospective Matched Case–Control Study on Medical Costs of Refractory Migraine in T aiwan
2013
·
Chao‐Hsiun Tang
, Yong‐Chen Chen
, et al.
·
Headache The Journal of Head and Face Pain
·
10
Show more works
View as search
Works count:
75
Citation count:
801
H-index:
16
I10-index:
25
Year
Topic
Type